Isis Pharma (NASDAQ: ISIS) has earned a $9 million milestone payment from Biogen Idec (Nasdaq: BIIB) related to advancing the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE